Open original FDA record ↗Recall record
- FDA identifier
- Z-2168-2025
- Company in FDA record
- Medtronic, Inc.
- FDA classification date
- Jul 23, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
In prior SmartSync application versions, the Abort button stopped the test that was selected. During an induction test, there was a limited window of time for the user to abort a therapy, thereby limiting the user's ability to cancel a high voltage therapy delivery.
Source facts
- Action
- An URGENT MEDICAL DEVICE CORRECTION NOTIFICATION letter dated 6/18/25 was sent to customers. Customer Actions: "Update SmartSync (to version 4.2.3 or higher). Refer to release notes provided by your local Medtronicrepresentative for update instructions. If needed, Medtronic representatives are available to work with you toinstall or update the SmartSync application(s) on your tablet. See Appendix for instructions on how to verify thesoftware update is complete. "Sign and return the enclosed confirmation form and share this notice with those who need to be aware withinyour organization or with any organization where SmartSync may be in use. Questions regarding this informationshould be directed to the local Medtronic Representative or Medtronic Programmer Technical Services at 800-638-1991, Option 1.
- Initiated
- 2025-06-18
- Root cause
- Software design
- Distribution
- Worldwide - US Nationwide distribution.
- Recall number
- Z-2168-2025
- Recall status
- Open, Classified
- CDRH record ID
- 214626
- FDA classified
- 2025-07-23
- Recall event number
- 97130